Danaher (DHR) had its price target lowered by Jefferies Financial Group Inc. from $265.00 to $240.00. They now have a "buy" rating on the stock.
Danaher (DHR) had its price target lowered by Wolfe Research from $260.00 to $230.00. They now have an "outperform" rating on the stock.
Global Validation, Calibration and Standardization in Life Sciences Market to Reach $3.9 Billion by 2030, Fueled by Regulatory Demands and Digital Transformation [Yahoo! Finance]
Danaher: A Great Way To Play Healthcare For Long-Term Dividend Growth Investors [Seeking Alpha]
Danaher (DHR) had its price target lowered by Evercore Inc from $254.00 to $225.00. They now have an "outperform" rating on the stock.